What is porcine liver hydrolysate used for in supplements?

Porcine liver hydrolysate is used primarily as a source of bioactive peptides believed to support cardiovascular health via ACE inhibition, antioxidant defense, and potentially body composition based on early animal research. It is also used in sports and general wellness supplements as a highly bioavailable, pre-digested protein source derived from pig liver. No human clinical trials currently confirm these effects.

Does porcine liver hydrolysate lower blood pressure?

In laboratory studies, porcine liver hydrolysate preparations produced with alcalase and bromelain have demonstrated measurable ACE-inhibitory activity, which is the same mechanism targeted by prescription drugs like lisinopril. However, no human trials have confirmed blood pressure reduction from supplementation, so it cannot be recommended as a blood pressure treatment. Individuals already taking antihypertensive medications should consult their doctor before use.

How is porcine liver hydrolysate made?

Porcine liver hydrolysate is produced by exposing pig liver tissue to digestive enzymes such as alcalase (a bacterial serine protease from Bacillus licheniformis) or bromelain (a cysteine protease from pineapple), which cleave peptide bonds and release short bioactive peptide fragments. The resulting mixture is filtered, concentrated, and typically dried into a powder for use in supplements. The specific peptide profile and bioactivity depend heavily on which enzyme or enzyme combination is used and the degree of hydrolysis achieved.

Is porcine liver hydrolysate safe to take daily?

As a food-derived protein hydrolysate, it is likely safe for most healthy adults in moderate supplemental doses, but no long-term safety studies have been conducted. A key concern is that porcine liver is inherently rich in preformed vitamin A (retinol), and concentrated hydrolysate products could contribute to cumulative retinol intake if combined with other vitamin A-containing supplements, raising the risk of toxicity with chronic high-dose use. People with gout, kidney disease, pork allergies, or those on antihypertensive or anticoagulant medications should consult a healthcare provider before daily use.

How does porcine liver hydrolysate compare to beef liver supplements?

Both porcine and bovine liver hydrolysates provide bioactive peptides, heme iron, B vitamins including B12, and preformed vitamin A, but their specific peptide sequences and bioactivities differ based on species-specific protein composition and processing methods. Research on ACE-inhibitory and antioxidant peptides is more documented in porcine preparations using alcalase and bromelain specifically, while beef liver supplements have a broader general nutritional evidence base. Neither form has robust human clinical trial data for specific therapeutic outcomes, making direct efficacy comparisons premature.

What does the research say about porcine liver hydrolysate and body fat reduction?

Current evidence for porcine liver hydrolysate and fat loss comes primarily from a single animal study in rats, which showed potential fat-reducing effects. However, this is preliminary research conducted in a controlled laboratory setting, and human clinical trials are needed to confirm whether similar benefits apply to people. The evidence quality is considered preliminary, so claims about weight management should be viewed cautiously until more robust human studies are available.

Is porcine liver hydrolysate safe for pregnant or breastfeeding women?

There is limited safety data on porcine liver hydrolysate use during pregnancy and breastfeeding. As an animal-derived supplement, pregnant and nursing women should consult their healthcare provider before use, particularly since liver concentrates contain high levels of vitamin A, which can pose risks at excessive doses during pregnancy. Safety in these populations has not been formally established in clinical studies.

Does porcine liver hydrolysate have antioxidant properties, and what does the evidence show?

Laboratory studies demonstrate that porcine liver hydrolysate exhibits antioxidant activity, particularly in preparations treated with enzymes like alcalase and bromelain. These in vitro findings suggest potential cellular protection benefits, but the evidence remains preliminary and limited to controlled laboratory conditions. Human studies are needed to determine whether these antioxidant properties translate into meaningful health effects when consumed as a supplement.

Porcine Liver Hydrolysate

Porcine liver hydrolysate is a protein digest derived from pig liver through enzymatic or acid hydrolysis, yielding bioactive peptides including angiotensin-converting enzyme (ACE) inhibitory sequences and antioxidant fragments. These peptides interact with the renin-angiotensin system and free radical scavenging pathways to produce cardiovascular and metabolic effects observed in preliminary research.

Category: Protein Evidence: 2/10 Tier: Emerging

Porcine Liver Hydrolysate — Hermetica Encyclopedia

Origin & History

Porcine Liver Hydrolysate is a protein-derived supplement obtained from the liver of domestic pigs (Sus scrofa domesticus), produced through enzymatic hydrolysis of fresh porcine liver tissue. The extraction process involves homogenizing liver with water, followed by incubation with proteases such as alcalase, bromelain, or papain for 7 hours, then enzyme deactivation at 95°C and centrifugation to yield a freeze-dried powder.

Historical & Cultural Context

No historical or traditional medicinal uses were identified in the research sources. The supplement represents a modern approach to utilizing meat by-products like pork liver for extraction of bioactive peptides through enzymatic processes.

Health Benefits

• May reduce body fat accumulation based on one animal study (PMID: 16428828) in rats - evidence quality: preliminary
• Demonstrates antioxidant activity in laboratory studies, particularly with alcalase/bromelain preparations (PMID: 35052531) - evidence quality: preliminary
• Shows ACE-inhibiting properties in vitro, suggesting potential cardiovascular benefits (PMID: 23292027) - evidence quality: preliminary
• Contains bioactive peptides identified via LC-MS/MS peptidomics with 44 differentially abundant peptides - evidence quality: preliminary
• Superior antioxidant capacity demonstrated in alcalase and bromelain hydrolysates compared to other enzyme preparations - evidence quality: preliminary

How It Works

Enzymatic hydrolysis of porcine liver protein with proteases such as alcalase or bromelain releases short-chain peptides that competitively inhibit angiotensin-converting enzyme (ACE), reducing the conversion of angiotensin I to the vasoconstrictive angiotensin II. Antioxidant peptides within the hydrolysate donate hydrogen atoms to neutralize reactive oxygen species (ROS) and chelate pro-oxidant metal ions, reducing lipid peroxidation. Additionally, unidentified peptide fractions may modulate lipid metabolism in hepatic tissue, as suggested by reduced fat accumulation observed in rat models, potentially through effects on fatty acid oxidation or lipogenic enzyme activity.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified for porcine liver hydrolysate; all evidence is limited to in vitro and animal studies. One rat study (PMID: 16428828) using Otsuka Long-Evans Tokushima Fatty rats showed reduced body fat accumulation, while in vitro studies demonstrate antioxidant and ACE-inhibiting effects (PMIDs: 23292027, 35052531).

Clinical Summary

The evidence base for porcine liver hydrolysate is currently limited to animal studies and in vitro laboratory experiments with no published human clinical trials identified. One rat study (PMID: 16428828) demonstrated a reduction in body fat accumulation in rodents supplemented with liver hydrolysate, though sample sizes, dosages, and mechanistic details from this preliminary model cannot be directly extrapolated to humans. In vitro research (PMID: 35052531) confirmed antioxidant activity in alcalase- and bromelain-derived preparations, with measurable DPPH radical scavenging capacity, and separate laboratory work identified ACE-inhibitory peptides in the hydrolysate fraction. Overall, the evidence quality is preliminary and speculative for human applications; controlled human trials are needed before any clinical claims can be substantiated.

Nutritional Profile

Porcine liver hydrolysate is a protein-rich ingredient derived from enzymatic or acid hydrolysis of pig liver tissue. Protein content typically ranges from 70-85% dry weight, composed of free amino acids (30-50% of total nitrogen) and short-chain peptides (di-, tri-, and oligopeptides). Amino acid profile is notably rich in essential amino acids: lysine (~7-9g/100g protein), leucine (~8-10g/100g protein), isoleucine (~4-5g/100g protein), valine (~5-6g/100g protein), and threonine (~4-5g/100g protein). Contains relatively high concentrations of glucogenic amino acids including alanine, glycine, and serine. Tryptophan content is moderate (~1-1.5g/100g protein). Retains micronutrients from the source liver tissue including heme iron (highly bioavailable form, approximately 3-6mg/100g), vitamin B12 (estimated 15-30mcg/100g dry weight), folate (~100-200mcg/100g), riboflavin (B2, ~2-4mg/100g), niacin (B3, ~10-15mg/100g), and zinc (~4-6mg/100g). Contains bioactive peptides generated during hydrolysis, including ACE-inhibitory peptides (sequences identified include LKPNM and VPP-analogues per PMID: 23292027) and antioxidant peptides with free radical scavenging capacity notably enhanced by alcalase and bromelain processing (PMID: 35052531). Fat content is low post-processing, typically 2-8% dry weight, with residual phospholipids including phosphatidylcholine. Carbohydrate content is negligible (<2%). Bioavailability of amino acids is high due to pre-digested peptide form, with absorption kinetics faster than intact protein; heme iron bioavailability estimated at 15-35% compared to 2-10% for non-heme iron. Degree of hydrolysis (DH) significantly affects peptide size distribution and bioactive properties, with higher DH (>20%) favoring greater free amino acid content and smaller bioactive peptides.

Preparation & Dosage

No clinically studied dosages in humans have been established due to absence of human trials. Animal studies do not specify standardized dosages, and the supplement is typically available as freeze-dried powder post-centrifugation with no established standardization protocols. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Milk thistle, N-acetylcysteine, Alpha-lipoic acid, Vitamin E, Selenium

Safety & Interactions

Porcine liver hydrolysate is generally recognized as a food-derived protein concentrate, but individuals with pork or meat allergies should avoid it due to risk of allergic reactions, including anaphylaxis in sensitized individuals. Because it contains ACE-inhibitory peptides, concurrent use with antihypertensive drugs such as ACE inhibitors (e.g., lisinopril, enalapril) or ARBs could theoretically produce additive blood pressure lowering, and caution is warranted. Porcine liver is naturally high in vitamin A precursors and purines; concentrated hydrolysate products may contribute to excess retinol intake or exacerbate hyperuricemia and gout in susceptible individuals. Pregnant women should exercise caution due to potential excess preformed vitamin A, and anyone on warfarin or other anticoagulants should consult a physician given the complex nutrient profile of organ-derived products.